These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18081638)

  • 1. Olanzapine monotherapy for late-onset vocal tics in a schizophrenic patient.
    Cheng WJ; Liu HC; Huang MC
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):700-1. PubMed ID: 18081638
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine vs haloperidol for treatment of schizophrenia.
    Glazer WM
    JAMA; 2004 Mar; 291(9):1064-5; author reply 1065-6. PubMed ID: 14996766
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in tardive dyskinesia symptoms during treatment with olanzapine or haloperidol.
    Kinon BJ; Kollack-Walker S; Stauffer V; Liu-Seifert H
    J Clin Psychopharmacol; 2012 Jun; 32(3):420-2. PubMed ID: 22561475
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine and haloperidol for residual symptoms.
    de Haan L; van Beveren N
    Am J Psychiatry; 2005 Jul; 162(7):1392-3; author reply 1393. PubMed ID: 15994737
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical antipsychotics, tardive dyskinesia, and D(2) receptors.
    Duggal HS; Mendhekar DN
    Am J Psychiatry; 2006 Aug; 163(8):1449-50. PubMed ID: 16877664
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.
    Blazer DG
    Am J Geriatr Psychiatry; 2004; 12(6):658-9; author reply 659-60. PubMed ID: 15545335
    [No Abstract]   [Full Text] [Related]  

  • 8. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol.
    Sayers SL; Campbell EC; Kondrich J; Mann SC; Cornish J; O'Brien C; Caroff SN
    J Nerv Ment Dis; 2005 Jun; 193(6):379-86. PubMed ID: 15920378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine vs haloperidol for treatment of schizophrenia.
    Volavka J; Citrome L
    JAMA; 2004 Mar; 291(9):1064; author reply 1065-6. PubMed ID: 14996765
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
    BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine-induced tardive dystonia successfully treated by tetrabenazine.
    Rauchverger B; Isakov V; Jabarin M
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):484-5. PubMed ID: 18070868
    [No Abstract]   [Full Text] [Related]  

  • 14. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient.
    Yoshida K; Higuchi H; Hishikawa Y
    Clin Neuropharmacol; 1998; 21(1):68-9. PubMed ID: 9579290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine vs haloperidol for treatment of schizophrenia.
    Amin M; Shukla VS
    JAMA; 2004 Mar; 291(9):1065; author reply 1065-6. PubMed ID: 14996767
    [No Abstract]   [Full Text] [Related]  

  • 19. Olanzapine for primary negative symptoms.
    Licht RW
    Am J Psychiatry; 1998 Aug; 155(8):1133-4. PubMed ID: 9699711
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
    Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.